Financiere Des Professionnels Fonds D,Investissement Inc. Halozyme Therapeutics, Inc. Transaction History
Financiere Des Professionnels Fonds D,Investissement Inc.
- $1.66 Trillion
- Q2 2025
A detailed history of Financiere Des Professionnels Fonds D,Investissement Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Financiere Des Professionnels Fonds D,Investissement Inc. holds 10,130 shares of HALO stock, worth $678,406. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,130Holding current value
$678,406% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
605Shares Held
127MCall Options Held
408KPut Options Held
388K-
Black Rock Inc. New York, NY17.6MShares$1.18 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$820 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$397 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$232 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$228 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.33B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...